Obesity and body weight control

February 14, 2018
Published by admin_auro at February 14, 2018
Categories

Molecular therapy for body weight control, energy homeostasis and TIIDM: Hydralazine[Trade name: Apresoline], an anti-hypertensive drug, increases REV-ERB and its down stream target genes, inhibits lipid accumulation, improves dyslipidemia and insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 14/February/2018, 7.07 am

Introduction: What they say A study from the Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida 33458, USA shows that “Regulation of circadian behaviour […]
Do you like it?0
Read more
February 8, 2018
Published by admin_auro at February 8, 2018
Categories

Molecular therapy for body weight control, energy homeostasis and TIIDM: A pharmaceutical mixture encompassing 17α-Estradiol and Aspirin  inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 8/February/2018, 11.03 pm

Introduction: What they say  A study from Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, United States shows that “Dnmt3a is an epigenetic mediator […]
Do you like it?0
Read more
February 6, 2018
Published by admin_auro at February 6, 2018
Categories

Molecular therapy for body weight control, energy homeostasis and TIIDM: D-β-Hydroxybutyrate (D-βHB) increases REV-ERB and its down stream target genes, inhibits lipid accumulation, improves dyslipidemia and insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 6/February/2018, 6.58 am

Introduction: What they say A study from the Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida 33458, USA shows that “Regulation of circadian behaviour […]
Do you like it?0
Read more
February 4, 2018
Published by admin_auro at February 4, 2018
Categories

Molecular therapy for body weight control, energy homeostasis and TIIDM: A pharmaceutical mixture encompassing Pyridoxamine and Triiodothyronine (T3) (PT3) inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 4/February/2018, 9.30 am

Introduction: What they say  A study from Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, United States shows that “Dnmt3a is an epigenetic mediator […]
Do you like it?0
Read more
Prev page
123456789101112
Next page